There’s been much chatter about 23andme’s recent downsizing and product restructuring.
Here’s an interesting perspective from a current employee on GlassDoor.
I’ve given in.
I’ve decided to take a closer look at my own genome through 23AndMe’s genotyping service.
Just some cursory observations so far. The experience from a consumer standpoint is stellar. In fact, it’s a bit like the Apple Experience: a great website, fast service, interesting packaging, and the anticipation of what’s inside.
I’ve been fortunate enough to experience first hand the transformation of DNA sequencing and array technology. Dating back to my time as a grad student sequencing alleles on long-running double-loaded polyacrylamide gels, reading the sequence on actual film (RainX is your friend), to the rise of institutional sequencing facilities, to full-scale genome sequencing and annotation projects.
And after almost 20 years working with molecular biology, genetics, and genomics data, I think I’m most amazed that the technology for personal discovery is starting to arrive. And what’s more, that it’s arriving in a little box sent through the mail.
After all these years of staring at the sequence of other species, it’s going to be interesting to take a peek at my own.